Notice NOT-MH-23-250 from the NIH Guide for Grants and Contracts

£34,619 - £43,592 per annum: Barts Cancer Institute , Queen Mary University London: Department: Barts Cancer Institute Salary: £34,619 - £43,592 per annum (Grade 4) Reference: QMUL31619 Location: Charterhouse Square Date posted: 19 Ma London, Greater London, England

£34,619 - £43,592 per annum: Barts Cancer Institute , Queen Mary University London: Department: Barts Cancer Institute Salary: £34,619 - £43,592 per annum (Grade 4) Reference: QMUL31609 Location: Charterhouse Square Date posted: 3 Apr London, Greater London, England

Notice NOT-OD-23-133 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-NS-24-003 from the NIH Guide for Grants and Contracts. This Notice of Funding Opportunity (NOFO) invites applications for a multisite study to comprehensively characterize ADRD relevant pathology related to cognitive impairment and dementia outcomes in persons with a history of traumatic brain injury (TBI). Investigations should elucidate the contribution of key individual (sex, age at time of injury, time since injury, social determinants of health, etc.) and injury characteristics (injury severity and frequency) to describe associations between neuropathological burden and antemortem clinicopathologic symptoms and outline the prevalence of TBI-related ADRD diagnoses, and CTE pathology in the participating brain banks. This NOFO intends to support applications that include retrospective samples, plans to acquire new brain tissue specimens, and methods to assess the antemortem symptomatology and clinical presentation. To further advance research in the area, broad sharing of clinical and neuropathological data will be a critical feature of successful applications, including the development of a digital resource for distribution and sharing of assessed neuropathological tissue.

Currently, biotechs waste huge sums of resources building data warehouses, analytical tools, and bioinformatic pipelines - effectively reinventing the wheel… $170,000 - $200,000 a year
From Recruiting From Scratch - Thu, 18 May 2023 20:28:47 GMT - View all Milwaukee, WI jobs

Currently, biotechs waste huge sums of resources building data warehouses, analytical tools, and bioinformatic pipelines - effectively reinventing the wheel… $170,000 - $200,000 a year
From Recruiting From Scratch - Thu, 18 May 2023 20:28:46 GMT - View all Seattle, WA jobs

Competitive: Charles River: For 75 years, Charles River employees have worked together to assist in the discovery, d Michigan (US)

Competitive: Charles River: For 70 years, Charles River employees have worked together to assist in the discovery, d Michigan (US)

Competitive: Charles River: For 75 years, Charles River employees have worked together to assist in the discovery, d Michigan (US)

Notice NOT-NS-23-085 from the NIH Guide for Grants and Contracts

Notice NOT-AG-23-027 from the NIH Guide for Grants and Contracts

Demonstrated experience in multi-omics analysis and application of data & modeling science in biology. The successful incumbent should demonstrate technical…
From Kimberly-Clark - Thu, 18 May 2023 10:00:27 GMT - View all Neenah, WI jobs

Notice NOT-OD-23-124 from the NIH Guide for Grants and Contracts

Notice NOT-DE-23-011 from the NIH Guide for Grants and Contracts

They work in close partnership with our Platforms teams to ensure we have the right tools and ways of working, and with our Bioinformatics teams to ensure the…
From GlaxoSmithKline - Thu, 18 May 2023 03:53:55 GMT - View all Seattle, WA jobs

Funding Opportunity RFA-HD-24-005 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to establish new Specialized Centers for Research on Health Disparities in Uterine Leiomyoma (SCHDULs). These centers will provide a platform to support novel, synergistic research programs involving multiple, high-quality projects spanning basic, clinical, translational, social sciences research to address health disparities (especially racial/ethnic disparities) in uterine fibroids.The established centers will aim to improve womens reproductive health and address modifiable aspects of the racial and associated health disparities in uterine fibroids through greater integrated understanding of biologic, behavioral, and environmental differences in risk, disease progression, and treatment.

Notice NOT-AA-23-013 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AG-24-038 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to stimulate the use of existing biospecimens and datasets (i.e., secondary analysis) which will increase our understanding of the clinical significance of clonal hematopoiesis (CH) mutations, their causality, directionality, relationships with different human aging phenotypes, and the underlying biological mechanisms.

Funding Opportunity RFA-AG-24-036 from the NIH Guide for Grants and Contracts. The purpose of this initiative is to develop measures of financial hardship associated with AD/ADRD that are responsive to the dyadic and family-level financial management arrangements that are common as AD/ADRD progresses. In order to accurately measure financial hardship among people and families living with AD/ADRD, validated screeners are needed to capture unique hardships associated with AD/ADRD that are not measured in screeners developed for people with cancer or in screeners developed for healthy households. This Notice of Funding Opportunity (NOFO) invites research to support the development of measures of financial hardship for persons living with AD/ADRD and their partners, families, or caregivers to facilitate research on financial health-a key social determinant of health- and health related quality of life among older adults with AD/ADRD.